Waters' Shares Rise as EPS Beats Street Estimate | GenomeWeb

This article has been updated to include additional comments from the firm's conference call.

NEW YORK (GenomeWeb News) – Shares of Waters soared in Tuesday afternoon trading after the firm reported earlier today a 10 percent drop in its first-quarter revenues, but an increase in profits and earnings per share that surpassed Wall Street estimates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.